Skip to main content

Table 1 Baseline characteristics of dogs assigned to each study group, and homogeneity analysis data, expressed as mean ± standard deviation and frequencies (%)

From: Prevention of disease progression in Leishmania infantum-infected dogs with dietary nucleotides and active hexose correlated compound

Variable

Supplement group

Placebo group

P-value supplement vs placeboa

Gender: female, n (%)

10 (50)

7 (31.8)

0.346

Age: months

63.75 ± 33.78

67.36 ± 31.05

0.720

Age groups: n (%)

  

1.000

  < 3 years

3 (15)

3 (13.6)

 

 3 to 8 years

13 (65)

15 (68.2)

 

  > 8 years

4 (20)

4 (18.2)

 

Clinical score: points

0.80 ± 1.28

0.95 ± 1.73

0.756

ELISA serology: arbitrary units

3.31 ± 1.53

2.38 ± 1.46

0.054

RT-PCR: parasites/ng of DNA

0.22 ± 0.54

0.66 ± 1.89

0.420

Body temperature: °C

38.33 ± 0.49

38.40 ± 0.41

0.590

Weight: kg

27.90 ± 12.10

25.78 ± 15.11

0.621

  1. aP-values were calculated with Student’s t-test for quantitative variables and Fisher’s exact test for categorical variables